Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (71-80 of 337) with videos related to

Pageof 34
Sort By:
Therapeutic Drug Monitoring|December 6, 2008
Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenationRoger J M Brüggemann, Tim Antonius, Arno van Heijst, et al.
Pharmacogenomics|December 19, 2024
Genetic variation on dolutegravir pharmacokinetics and relation to safety and efficacy outcomes: a systematic reviewLisanne A H Bevers, Rebecca L Jensen, Andrew Owen, et al.
Pharmacogenomics|October 25, 2017
Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patientsKanokrat Rungtivasuwan, Anchalee Avihingsanon, Narukjaporn Thammajaruk, et al.
International Journal of Antimicrobial Agents|March 12, 2020
Crushed application of sofosbuvir and velpatasvir in a patient with swallowing disorderMinou van Seyen, Anda D Samson, Lorraine Cullen, et al.
Therapeutic Drug Monitoring|June 20, 2014
Pharmacological interactions between rifampicin and antiretroviral drugs: challenges and research priorities for resource-limited settingsHadija H Semvua, Gibson S Kibiki, Elton R Kisanga, et al.
United European Gastroenterology Journal|August 18, 2017
The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactionsElise J Smolders, Floor Ac Berden, Clara Tmm de Kanter, et al.
The Pediatric Infectious Disease Journal|December 4, 2010
Impact of therapeutic drug monitoring of voriconazole in a pediatric populationRoger J M Brüggemann, Jan W M van der Linden, Paul E Verweij, et al.
Clinical Pharmacokinetics|August 10, 2017
Clinical Pharmacokinetics and Pharmacodynamics of MicafunginRoeland E Wasmann, Eline W Muilwijk, David M Burger, et al.
Antiviral Therapy|April 4, 2017
Zidovudine continuous infusion in an HIV-infected pregnant woman with a phobia of swallowing pillsMatthijs van Luin, Gerjanne Ter Beest, Lia E Wijnberger, et al.
Plos One|March 24, 2017
Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infectionKay Seden, Sara Gibbons, Catia Marzolini, et al.
Pageof 34

Showing results (71-80 of 337) with videos related to

Sort By:
Pageof 34
Therapeutic Drug Monitoring|December 6, 2008
Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenationRoger J M Brüggemann, Tim Antonius, Arno van Heijst, et al.
Pharmacogenomics|December 19, 2024
Genetic variation on dolutegravir pharmacokinetics and relation to safety and efficacy outcomes: a systematic reviewLisanne A H Bevers, Rebecca L Jensen, Andrew Owen, et al.
Pharmacogenomics|October 25, 2017
Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patientsKanokrat Rungtivasuwan, Anchalee Avihingsanon, Narukjaporn Thammajaruk, et al.
International Journal of Antimicrobial Agents|March 12, 2020
Crushed application of sofosbuvir and velpatasvir in a patient with swallowing disorderMinou van Seyen, Anda D Samson, Lorraine Cullen, et al.
Therapeutic Drug Monitoring|June 20, 2014
Pharmacological interactions between rifampicin and antiretroviral drugs: challenges and research priorities for resource-limited settingsHadija H Semvua, Gibson S Kibiki, Elton R Kisanga, et al.
United European Gastroenterology Journal|August 18, 2017
The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactionsElise J Smolders, Floor Ac Berden, Clara Tmm de Kanter, et al.
The Pediatric Infectious Disease Journal|December 4, 2010
Impact of therapeutic drug monitoring of voriconazole in a pediatric populationRoger J M Brüggemann, Jan W M van der Linden, Paul E Verweij, et al.
Clinical Pharmacokinetics|August 10, 2017
Clinical Pharmacokinetics and Pharmacodynamics of MicafunginRoeland E Wasmann, Eline W Muilwijk, David M Burger, et al.
Antiviral Therapy|April 4, 2017
Zidovudine continuous infusion in an HIV-infected pregnant woman with a phobia of swallowing pillsMatthijs van Luin, Gerjanne Ter Beest, Lia E Wijnberger, et al.
Plos One|March 24, 2017
Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infectionKay Seden, Sara Gibbons, Catia Marzolini, et al.
Pageof 34